Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Feb 1:6:20092.
doi: 10.1038/srep20092.

Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2

Affiliations
Meta-Analysis

Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2

Jennifer J Ware et al. Sci Rep. .

Abstract

Genome-wide association studies (GWAS) of complex behavioural phenotypes such as cigarette smoking typically employ self-report phenotypes. However, precise biomarker phenotypes may afford greater statistical power and identify novel variants. Here we report the results of a GWAS meta-analysis of levels of cotinine, the primary metabolite of nicotine, in 4,548 daily smokers of European ancestry. We identified a locus close to UGT2B10 at 4q13.2 (minimum p = 5.89 × 10(-10) for rs114612145), which was consequently replicated. This variant is in high linkage disequilibrium with a known functional variant in the UGT2B10 gene which is associated with reduced nicotine and cotinine glucuronidation activity, but intriguingly is not associated with nicotine intake. Additionally, we observed association between multiple variants within the 15q25.1 region and cotinine levels, all located within the CHRNA5-A3-B4 gene cluster or adjacent genes, consistent with previous much larger GWAS using self-report measures of smoking quantity. These results clearly illustrate the increase in power afforded by using precise biomarker measures in GWAS. Perhaps more importantly however, they also highlight that biomarkers do not always mark the phenotype of interest. The use of metabolite data as a proxy for environmental exposures should be carefully considered in the context of individual differences in metabolic pathways.

PubMed Disclaimer

Conflict of interest statement

TK and JK have acted as consultants on nicotine dependence for Pfizer (2011-2014). RFT has consulted for pharmaceutical companies, primarily in relation to smoking cessation.

Figures

Figure 1
Figure 1. Manhattan and quantile-quantile plots illustrating genome-wide meta-analysis results.
Manhattan plot (A): All SNPs plotted on x-axis according to their position on each chromosome, against their association with cotinine level, as shown on the y-axis as –log10 p-value. QQ plot (B): The observed distribution of p-values (y-axis) against the expected distribution of p-values under the null hypothesis (x-axis). Plots includes variants which were genotyped or imputed in at least 3,000 individuals only (~7 M SNPs).
Figure 2
Figure 2. Forest and regional plots of associations for cotinine from genome-wide meta-analysis.
Forest plots illustrate effect size and 95% confidence intervals (CIs) observed in each contributing study for chromosome 15 (A) and chromosome 4 (B) SNPs with smallest p-values (“top” SNPs). Regional plots show SNPs plotted by their positions on chromosomes against –log10 p-value for their association with cotinine level in genome-wide meta-analysis. The top SNP in each region is highlighted in purple. The SNPs surrounding each top SNP are colour coded to reflect their LD with this variant (see legend). Estimated recombination rates are plotted in pale blue to reflect local LD structure on secondary y-axis. Genome build = hg19; LD population = 1000 Genomes March 2012 release (EUR). Regional plots generated using Locus Zoom.

References

    1. Furberg H. et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genetics 42, 441–447, 10.1038/ng.571 (2010). - DOI - PMC - PubMed
    1. Thorgeirsson T. E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642, 10.1038/nature06846 (2008). - DOI - PMC - PubMed
    1. Liu J. Z. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 42, 436–440, 10.1038/ng.572 (2010). - DOI - PMC - PubMed
    1. Thorgeirsson T. E. et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics 42, 448–453, 10.1038/ng.573 (2010). - DOI - PMC - PubMed
    1. Munafo M. R. et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. Journal of the National Cancer Institute 104, 740–748, 10.1093/jnci/djs191 (2012). - DOI - PMC - PubMed

Publication types